Article ID Journal Published Year Pages File Type
1365513 Bioorganic & Medicinal Chemistry Letters 2007 5 Pages PDF
Abstract

Small molecule agonists and antagonists of the V2-vasopressin receptor have been discovered and have undergone clinical trials. In conjunction with these discovery programs, the synthesis and biological testing of various metabolites associated with these clinical targets were actively pursued. We now report the results of our synthetic efforts and the corresponding biological data generated for several of the metabolites of WAY-151932 and CL-347985 (Lixivaptan®).

Graphical abstractThe synthesis and biological results for metabolites of the above vasopressin agonist 1 and antagonist 2 are presented.Figure optionsDownload full-size imageDownload as PowerPoint slide

Keywords
Related Topics
Physical Sciences and Engineering Chemistry Organic Chemistry
Authors
, , , , , , , , , ,